SEARCH   
MEMBER LOGIN      
Forgot Password?

Basic Pharmaceutical Product Manufacturing in the UK: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Basic Pharmaceutical Product Manufacturing Market Research Report | SIC C21.100 | Mar 2017

Spoonful of sugar: Rising export revenue is expected to support growth through the current year

The Basic Pharmaceutical Product Manufacturing market research report provides key industry analysis and industry statistics, measures market size, analyzes current and future industry trends and shows market share for the industry’s largest companies. IBISWorld publishes the largest collection of industry reports so you can see an industry’s supply chain, economic drivers and key buyers and markets.

Report Snapshot
Market Share of Companies
AstraZeneca UK Ltd AstraZeneca UK Ltd market share
GSK GSK market share
Novartis UK Ltd Novartis UK Ltd market share
Industry Statistics & Market Size
Revenue
£1bn
Annual Growth 12-17
-2.6%
Annual Growth 17-22
Purchase to read more
Profit
Purchase to read more
Employment
7,694
Businesses
169
Industry Threats & Opportunities
  • Revenue has been volatile, and recent expansion has not outweighed overall decline
  • The sharp fall in the value of the pound has boosted exports, supporting growth in the current year
  • The development of new boutique drugs is expected to provide operators with an opportunity for growth
  • ... purchase to read more

Industry Analysis & Industry Trends

The UK pharmaceutical sector commands an important position in the UK economy, and Britain is one of the world's largest exporters of pharmaceuticals by value. One small, albeit important, component of the sector is the Basic Pharmaceutical Product Manufacturing industry, which manufactures active substances used for their pharmacological properties to make medicines. The industry is an integral part of the pharmaceutical supply chain and the pharmaceutical sector's research and development (R&D) process.

Industry revenue has declined during the past five years, driven by declining exports in the middle of the period. Over the five years through 2016-17, industry revenue is estimated to decline at a compound annual rate of... purchase to read more

Industry Report - Industry Investment Chapter

The level of capital intensity is determined by comparing the human and capital equipment factors of production using wages and depreciation costs as proxies. Comparatively high depreciation costs indicate a high level of investment in depreciable assets, such as buildings and equipment, and therefore moderate capital intensity. Conversely, comparatively high wage costs indicate high labour intensity.

The Basic Pharmaceutical Product Manufacturing industry has a moderate level of capital intensity. In 2016-17, IBISWorld estimates that industry players will spend £3.28 on labour for every £1.00 they spend on capital.

.. purchase to read more

Additional Insights for the Basic Pharmaceutical Product Manufacturing Industry

IBISWorld identifies 250 Key Success Factors for a business.The most important for the Basic Pharmaceutical Product Manufacturing Industry are

  • Having technology sharing arrangements with major players
  • Ability to alter goods and services produced in favour of market conditions
  • Effective cost controls
  • IBISWorld analysts also discuss how external factors such as Population aged 65 years and over and Total health expenditure in the Basic Pharmaceutical Product Manufacturing industry impact industry performance... purchase to read more

     


    Industry ProductsRelated Reports

    What is the Basic Pharmaceutical Product Manufacturing Industry?

    Companies in the Basic Pharmaceutical Product Manufacturing industry manufacture medicinal active substances that are used for their pharmacological properties to make medications, including antibiotics, basic vitamins, salicylic acids and aspirin. The industry also includes companies that process blood and glands and manufacture chemically pure sugars.

    Industry Products
    Human and animal blood processingChemically pure sugarsActive product ingredients
     
    Industry Activities
    Blood processingManufacturing medicinal active substancesManufacturing chemically pure sugarsProcessing glands and extracts from glands


    Table of Contents
    About this Industry
    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry at a Glance
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Industry Performance
    Executive Summary
    Key External Drivers
  • Population aged 65 years and over
  • Total health expenditure
  • Demand from pharmaceutical preparations manufacturing
  • Real effective exchange rate
  • Current Performance
  • Growth constraints
  • Exports support growth
  • Regulatory changes
  • Declining manufacturing
  • Advancements and profitability
  • Chart: Revenue Growth
  • Industry Outlook
  • Dull conditions
  • Growth constraints
  • Favourable factors
  • Profitability under pressure
  • Table: Basic Pharmaceutical Product Manufacturing Industry Revenue Outlook
  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Basic Pharmaceutical Product Manufacturing Industry Lifecycle vs The Economy
  • Products & Markets
    Supply Chains
  • Key Buying Industries
  • Pharmaceutical Preparations Manufacturing
  • Hospitals
  • Biotechnology
  • Key Selling Industries
  • Inorganic Basic Chemical Manufacturing
  • Research and Experimental Development on Biotechnology
  • Products & Services
  • Active product ingredients
  • Human and animal blood processing
  • Other
  • Chemically pure sugars
  • Chart: Basic Pharmaceutical Product Manufacturing Industry Products and Services Segmentation
  • Demand Determinants
    Major Markets
  • Pharmaceutical preparations manufacturers
  • Hospitals
  • Other
  • Chart: Major Market Segmentation for the Basic Pharmaceutical Product Manufacturing Industry
  • International Trade
    Business Locations
  • Chart: Business Locations by State
  • Competitive Landscape
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
  • Profit
  • Purchases
  • Wages
  • Depreciation
  • Research and development
  • Other costs
  • Chart: Cost Structure Benchmarking – Sector vs Basic Pharmaceutical Product Manufacturing
  • Basis of Competition
  • Internal competition
  • External competition
  • Barriers to Entry
  • Table: Barrier to Entry Checklist for the Basic Pharmaceutical Product Manufacturing Industry
  • Industry Globalization
    Major Companies
    Novartis UK Ltd
    GlaxoSmithKline plc
    AstraZeneca UK Ltd
  • Table: Novartis UK Ltd - financial performance
  • Table: GlaxoSmithKline plc - financial performance
  • Table: AstraZeneca UK Ltd - financial performance
  • Operating Conditions
    Capital Intensity
  • Chart: Level of Capital Intensity for the Basic Pharmaceutical Product Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success
  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth
  • Regulation & Policy
    Industry Assistance
    Key Statistics
  • Table: Industry Data for the Basic Pharmaceutical Product Manufacturing Industry
  • Includes:
  • Industry Revenue (2008-2022)
  • Industry Gross Product (2008-2022)
  • Establishments (2008-2022)
  • Businesses (2008-2022)
  • Employment (2008-2022)
  • Exports (2008-2022)
  • Imports (2008-2022)
  • Wages (2008-2022)
  • Table: Annual Percentage Change for Key Industry Data
  • Table: Key Ratios for Industry Key Data
  • Jargon & Glossary
    Active Pharmaceutical Ingredient (Api)
  • The biologically active substance in a pharmaceutical drug.
  • Biopharmaceuticals
  • Pharmaceuticals derived from biological sources such as vaccines and stem cell therapies
  • Blockbuster Drug
  • An extremely popular drug that generates annual sales over $1 billion for the company that owns it
  • Generic Drug
  • A drug with the same active ingredients as the patented original, but which is produced and distributed without patent protection.
  • Good Manufacturing Practice (Gmp)
  • A quality-control system for manufacturing active pharmaceutical ingredients and products.

  • Why Buy this Report?
    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Basic Pharmaceutical Product Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Basic Pharmaceutical Product Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Basic Pharmaceutical Product Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    View Sample
    Quote
    Select Clients
    Back to Top